Molecular physiology of platelet ADP receptors

被引:1
作者
Kunapuli, SP
机构
[1] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA
关键词
platelets; P2; receptors; P2Y(1) receptor; P2T receptor; ADP receptor; platelet aggregation;
D O I
10.1002/(SICI)1098-2299(199811/12)45:3/4<135::AID-DDR8>3.0.CO;2-B
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Extracellular nucleotides have been implicated in a number of physiologic functions. Nucleotides act on cell surface receptors known as P2 receptors of which several subtypes have been cloned. Both ATP and ADP are stored in platelets and are released upon platelet activation. During vascular injury, nucleotides play an important role in hemostasis by activating platelets. Classic pharmacologic studies have identified ADP receptors on platelets, designated P2T receptor. The P2T receptor is now resolved into three P2 receptor subtypes, the P2Y(1), the P2X(1), and the P2T(AC) receptor, which remains to be cloned. Although the P2Y(1) receptor solely mediates ADP-induced platelet shape change, both the P2Y1 and P2T(AC) receptors are essential for ADP-induced fibrinogen receptor activation on platelets. The function of the P2X(1) receptor remains to be elucidated. Thus the complexities in the functional characterization of platelet ADP receptors now appear to be resolved. Drug Dev. Res. 45:135-139, 1998. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 47 条
[1]   AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE AND ITS REVERSAL [J].
BORN, GVR .
NATURE, 1962, 194 (4832) :927-&
[2]  
Boyer JL, 1996, MOL PHARMACOL, V50, P1323
[3]  
CATTANEO M, 1992, BLOOD, V80, P2787
[4]   ADENOSINE 5'-DIPHOSPHATE ANTAGONISTS AND HUMAN-PLATELETS - NO EVIDENCE THAT AGGREGATION AND INHIBITION OF STIMULATED ADENYLATE-CYCLASE ARE MEDIATED BY DIFFERENT RECEPTORS [J].
CUSACK, NJ ;
HOURANI, SMO .
BRITISH JOURNAL OF PHARMACOLOGY, 1982, 76 (01) :221-227
[5]   Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets [J].
Daniel, JL ;
Dangelmaier, C ;
Jin, JG ;
Ashby, B ;
Smith, JB ;
Kunapuli, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2024-2029
[6]  
DEFREYN G, 1991, THROMB HAEMOSTASIS, V65, P186
[7]   P2Y1-receptors in human platelets which are pharmacologically distinct from P2YADP-receptors [J].
Fagura, MS ;
Dainty, IA ;
McKay, GD ;
Kirk, IP ;
Humphries, RG ;
Robertson, MJ ;
Dougall, IG ;
Leff, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) :157-164
[8]   Towards a revised nomenclature for P1 and P2 receptors [J].
Fredholm, BB ;
Abbracchio, MP ;
Burnstock, G ;
Dubyak, GR ;
Harden, TK ;
Jacobson, KA ;
Schwabe, U ;
Williams, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (03) :79-82
[9]  
GAARDER A., 1961, NATURE, V192, P531, DOI 10.1038/192531a0
[10]   THE THIENOPYRIDINE TICLOPIDINE SELECTIVELY PREVENTS THE INHIBITORY EFFECTS OF ADP BUT NOT OF ADRENALINE ON CAMP LEVELS RAISED BY STIMULATION OF THE ADENYLATE-CYCLASE OF HUMAN PLATELETS BY PGE1 [J].
GACHET, C ;
CAZENAVE, JP ;
OHLMANN, P ;
BOULOUX, C ;
DEFREYN, G ;
DRIOT, F ;
MAFFRAND, JP .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (12) :2683-2687